Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two ...

Lilly (NYSE: LLY) makes drugs including Mounjaro for type 2 diabetes and Zepbound for obesity. For 2023, it reported $34 ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q3 2024 earnings call. [Operator ...

Ladies and gentlemen, thank you for standing-by, and welcome to the Lilly Q3 2024 Earnings Call. [Operator Instructions] I ...

FILE - This April 26, 2017 file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. (AP Photo/Darron Cummings, File) (Darron Cummings, Copyright ...

Thanks for joining us for Eli Lilly and Company's Q3 2024 earnings ... a short drive from the corporate headquarters. This investment underscores our confidence in our pipeline and the urgency ...

As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...

Eli Lilly's IE2b was recognized as a winner in ... In close communication, Lilly's headquarters staff trialed the platform's miniaturized prototypes to inform design and construction, which ...

Ahead of the event, analysts expect LLY to report a profit of $1.98 per share on a diluted basis, up significantly from $0.10 per share in the year-ago quarter. The company has consistently surpassed ...

Four days after a compounding industry group filed a lawsuit against the FDA for removing Eli Lilly ... from its headquarters in Indianapolis. That outlay comes on top of Lilly committing ...

So T1International kept pushing. Its most visible actions were repeated demonstrations outside the Indianapolis headquarters of Eli Lilly and Company, one of the three major global insulin ...